{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:19:51Z","timestamp":1780755591408,"version":"3.54.1"},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej22-0585","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T22:09:43Z","timestamp":1676498983000},"page":"489-500","source":"Crossref","is-referenced-by-count":13,"title":["Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism"],"prefix":"10.1507","volume":"70","author":[{"given":"Hiroki","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Division of Nephrology, Hypertension, and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension, and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension, and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, National Center for Global Health and Medicine, Tokyo 162-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Endocrinology, Department of Internal Medicine, St Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama 241-0811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Medical Education, National Defense Medical College, Tokorozawa 359-8513, Japan"},{"name":"Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Ichijo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Saiseikai Yokohamashi Tobu Hospital, Yokohama 230-8765, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Tsuiki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Izawa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago 683-8504, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo 060-8604, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-0934, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Showa General Hospital, Kodaira 187-0002, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[{"name":"Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"},{"name":"Endocrine Center and Clinical Research Center, Ijinkai Takeda General Hospital, Kyoto 601-1495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"JPAS\/JRAS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193\u2013202.","DOI":"10.1291\/hypres.27.193"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045\u20131050.","DOI":"10.1210\/jc.2003-031337"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, et al. (2006). A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48: 2293\u20132300.","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, et al. (2017) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69: 1811\u20131820.","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, et al. (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168: 80\u201385.","DOI":"10.1001\/archinternmed.2007.33"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Guo Z, Poglitsch M, McWhinney BC, Ungerer JPJ, Ahmed AH, et al. (2018) Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. J Clin Endocrinol Metab 103: 3965\u20133973.","DOI":"10.1210\/jc.2018-01041"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Nishikawa T, Omura M, Kawaguchi M, Takatsu A, Satoh F, et al. (2016) Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood. Endocr J 63: 1065\u20131080.","DOI":"10.1507\/endocrj.EJ16-0304"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Morimoto R, Ono Y, Tezuka Y, Kudo M, Yamamoto S, et al. (2017) Rapid screening of primary aldosteronism by a novel chemiluminescent immunoassay. Hypertension 70: 334\u2013341.","DOI":"10.1161\/HYPERTENSIONAHA.117.09078"},{"key":"9","unstructured":"9 National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan. https:\/\/unit.aist.go.jp\/nmij\/ accessed on February 1, 2021 (In Japanese)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Teruyama K, Naruse M, Tsuiki M, Kobayashi H (2022) Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism. J Hum Hypertens 36: 77\u201385.","DOI":"10.1038\/s41371-020-00465-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011). Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J 58: 711\u2013721.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, et al. (2014) The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res 37: 253\u2013390.","DOI":"10.1038\/hr.2014.20"},{"key":"13","unstructured":"13 Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, et al. (2017). Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5: 689\u2013699."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, et al. (2018) Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism. J Endocr Soc 2: 893\u2013902.","DOI":"10.1210\/js.2018-00055"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Kurihara I, et al. (2019). Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. J Hypertens 37: 1077\u20131082.","DOI":"10.1097\/HJH.0000000000001964"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, et al. (2012) The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 97: 1606\u20131614.","DOI":"10.1210\/jc.2011-2830"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Webb R, Mathur A, Chang R, Baid S, Nilubol N, et al. (2012) What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism? Ann Surg Oncol 19: 1881\u20131886.","DOI":"10.1245\/s10434-011-2121-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, et al. (2004) Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 50: 1650\u20131655.","DOI":"10.1373\/clinchem.2004.033159"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Burrello J, Monticone S, Buffolo F, Lucchiari M, Tetti M, et al. (2016) Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. J Hypertens 34: 920\u2013927.","DOI":"10.1097\/HJH.0000000000000880"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Rossi GP, Ceolotto G, Rossitto G, Seccia TM, Maiolino G, et al. (2016) Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension. Clin Chem Lab Med 54: 1441\u20131450.","DOI":"10.1515\/cclm-2015-1094"},{"key":"21","unstructured":"21 Conn JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3\u201317."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol 3: 768\u2013774.","DOI":"10.1001\/jamacardio.2018.2003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension 72: 658\u2013666.","DOI":"10.1161\/HYPERTENSIONAHA.118.11568"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 6: 51\u201359.","DOI":"10.1016\/S2213-8587(17)30367-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ohno Y, Naruse M, Beuschlein F, Schreiner F, Parasiliti-Caprino M, et al. (2021) Adrenal venous sampling-guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT). J Clin Endocrinol Metab 106: e1400\u2013e1407.","DOI":"10.1210\/clinem\/dgaa706"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Sartori M, Cal\u00f2 LA, Mascagna V, Realdi A, Macchini L, et al. (2006) Aldosterone and refractory hypertension: a prospective cohort study. Am J Hypertens 19: 373\u2013379; discussion 380.","DOI":"10.1016\/j.amjhyper.2005.06.031"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Shibata H, Itoh H (2012) Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension. Am J Hypertens 25: 514\u2013523.","DOI":"10.1038\/ajh.2011.245"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Tanaka A, Shibata H, Node K (2020) Suspected borderline aldosteronism in hypertension: the next target? J Am Coll Cardiol 76: 759\u2013760.","DOI":"10.1016\/j.jacc.2020.05.071"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, et al. (2020) The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med 173: 10\u201320.","DOI":"10.7326\/M20-0065"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101: 1889\u20131916.","DOI":"10.1210\/jc.2015-4061"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Lechner B, Lechner K, Heinrich D, Adolf C, Holler F, et al. (2019) Therapy of endocrine disease: medical treatment of primary aldosteronism. Eur J Endocrinol 181: R147\u2013R153.","DOI":"10.1530\/EJE-19-0215"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, et al. (2003) Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab 88: 2489\u20132494.","DOI":"10.1210\/jc.2002-021476"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Vermue FC, van den Berg SAA (2021) Validation of the Fujirebio Lumipulse G1200 aldosterone assay for measurements during adrenal venous sampling for primary hyperaldosteronism. Clin Chem Lab Med 59: e442\u2013e444.","DOI":"10.1515\/cclm-2021-0102"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/5\/70_EJ22-0585\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:45:33Z","timestamp":1715316333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/5\/70_EJ22-0585\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0585","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ22-0585"}}